By Professor Emad El-Omar

Journal articles

Chen YC; Malfertheiner P; Yu HT; Kuo CL; Chang YY; Meng FT; Wu YX; Hsiao JL; Chen MJ; Lin KP; Wu CY; Lin JT; O'Morain C; Megraud F; Lee WC; El-Omar EM; Wu MS; Liou JM, 2024, 'Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022', Gastroenterology, 166, pp. 605 - 619, http://dx.doi.org/10.1053/j.gastro.2023.12.022

Rugge M; Genta RM; Malfertheiner P; Dinis-Ribeiro M; El-Serag H; Graham DY; Kuipers EJ; Leung WK; Park JY; Rokkas T; Schulz C; El-Omar EM, 2024, 'RE.GA.IN.: the Real-world Gastritis Initiative-updating the updates', Gut, 73, pp. 407 - 441, http://dx.doi.org/10.1136/gutjnl-2023-331164

Moore KH; Ognenovska S; Chua XY; Chen Z; Hicks C; El-Assaad F; te West N; El-Omar E, 2024, 'Change in microbiota profile after vaginal estriol cream in postmenopausal women with stress incontinence', Frontiers in Microbiology, 15, http://dx.doi.org/10.3389/fmicb.2024.1302819

Hong TC; El-Omar EM; Kuo YT; Wu JY; Chen MJ; Chen CC; Fang YJ; Leow AHR; Lu H; Lin JT; Tu YK; Yamaoka Y; Wu MS; Liou JM; Chen YC; Chang YY, 2024, 'Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis', The Lancet Gastroenterology and Hepatology, 9, pp. 56 - 67, http://dx.doi.org/10.1016/S2468-1253(23)00281-9

Malfertheiner P; Camargo MC; El-Omar E; Liou JM; Peek R; Schulz C; Smith SI; Suerbaum S, 2023, 'Helicobacter pylori infection', Nature Reviews Disease Primers, 9, http://dx.doi.org/10.1038/s41572-023-00431-8

Li P; Shuai P; Shen S; Zheng H; Sun P; Zhang R; Lan S; Lan Z; Jayawardana T; Yang Y; Zhao J; Liu Y; Chen X; El-Omar EM; Wan Z, 2023, 'Perturbations in gut microbiota composition in patients with polycystic ovary syndrome: a systematic review and meta-analysis', BMC Medicine, 21, http://dx.doi.org/10.1186/s12916-023-02975-8

Omary MB; Leddin D; Metz G; Veitch AM; El-Omar EM; Macedo G; Perman ML, 2023, 'World Gastroenterology Organisation - Gut commentary series on digestive health and climate change', Gut, 72, pp. 2193 - 2196, http://dx.doi.org/10.1136/gutjnl-2023-331193

Zhang N; Zhu W; Zhang S; Liu T; Gong L; Wang Z; Zhang W; Cui Y; Wu Q; Li J; Yu H; El-Omar EM; Hao J; Lu W, 2023, 'A Novel Bifidobacterium/Klebsiella Ratio in Characterization Analysis of the Gut and Bile Microbiota of CCA Patients', Microbial Ecology, 87, http://dx.doi.org/10.1007/s00248-023-02318-3

Strout N; Pasic L; Hicks C; Chua XY; Tashvighi N; Butler P; Liu Z; El-Assaad F; Holmes E; Susic D; Samaras K; Craig ME; Davis GK; Henry A; Ledger WL; El-Omar EM, 2023, 'The MothersBabies Study, an Australian Prospective Cohort Study Analyzing the Microbiome in the Preconception and Perinatal Period to Determine Risk of Adverse Pregnancy, Postpartum, and Child-Related Health Outcomes: Study Protocol', International Journal of Environmental Research and Public Health, 20, pp. 6736, http://dx.doi.org/10.3390/ijerph20186736

Chen MJ; Chen PY; Fang YJ; Bair MJ; Chen CC; Chen CC; Yang TH; Lee JY; Yu CC; Kuo CC; Chiu MC; Chou CK; Chen CY; Hu WH; Tsai MH; Hsu YC; Shun CT; Luo JC; Lin JT; El-Omar EM; Wu MS; Liou JM, 2023, 'Molecular testing-guided therapy versus susceptibility testing-guided therapy in first-line and third-line Helicobacter pylori eradication: two multicentre, open-label, randomised controlled, non-inferiority trials', The Lancet Gastroenterology and Hepatology, 8, pp. 623 - 634, http://dx.doi.org/10.1016/S2468-1253(23)00097-3

Camilleri M; El-Omar EM, 2023, 'Ten reasons gastroenterologists and hepatologists should be treating obesity', Gut, 72, pp. 1033 - 1038, http://dx.doi.org/10.1136/gutjnl-2023-329639

Liou JM; Jiang XT; Chen CC; Luo JC; Bair MJ; Chen PY; Chou CK; Fang YJ; Chen MJ; Chen CC; Lee JY; Yang TH; Yu CC; Kuo CC; Chiu MC; Chen CY; Shun CT; Hu WH; Tsai MH; Hsu YC; Tseng CH; Chang CY; Lin JT; El-Omar EM; Wu MS; Wu CY; Lee YC; Tseng PH; Wu JY; Tai CM; Lee CT; Wang WL, 2023, 'Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial', The Lancet Gastroenterology and Hepatology, 8, pp. 228 - 241, http://dx.doi.org/10.1016/S2468-1253(22)00384-3

Gow ML; Chua XY; El-Omar E; Susic D; Henry A, 2023, 'Relationship between Diet Quality and Maternal Stool Microbiota in the MUMS Australian Pregnancy Cohort', Nutrients, 15, pp. 689, http://dx.doi.org/10.3390/nu15030689

Zhang F; Gia A; Chen G; Gong L; Behary J; Hold GL; Zekry A; Tang X; Sun Y; El-Omar E; Jiang XT, 2023, 'Critical Assessment of Whole Genome and Viral Enrichment Shotgun Metagenome on the Characterization of Stool Total Virome in Hepatocellular Carcinoma Patients', Viruses, 15, http://dx.doi.org/10.3390/v15010053

Maloney S; Tebbutt N; Nikfarjam M; Samra J; Mendis S; Tie J; Christopherson L; Hayes S; Berthon-Jones N; Yim CHH; El-Omar E; Chantrill L, 2023, '1683TiP Trial in progress: NEO-adjuvant chemo-IMmunotherapy in PAnCreaTic cancer-NEO-IMPACT', Annals of Oncology, 34, pp. S922 - S922, http://dx.doi.org/10.1016/j.annonc.2023.09.2630

Liou J-M; Chen M-J; Chen P-Y; Chen C-C; Lin J-T; El-Omar EM; Wu M-S, 2023, '267 GENOTYPIC RESISTANCE GUIDED THERAPY VERSUS SUSCEPTIBILITY TESTING GUIDED THERAPY IN THE FIRST-LINE AND THIRD-LINE TREATMENT OF HELICOBACTER PYLORI INFECTION-TWO MULTICENTER RANDOMIZED CONTROLLED TRIALS', Gastroenterology, 164, pp. S - 46, http://dx.doi.org/10.1016/s0016-5085(23)01068-5

El-Omar EM, 2023, 'Future directions in the microbiome field: an editor’s perspective', eGastroenterology, 1, pp. e100003 - e100003, http://dx.doi.org/10.1136/egastro-2023-100003

Zekry A; El-Omar EM, 2022, 'A Tale of Two Fibers: A Liver Twist!', Gastroenterology, 163, pp. 1495 - 1497, http://dx.doi.org/10.1053/j.gastro.2022.09.012

Pandey D; Szczesniak M; Maclean J; Yim HCH; Zhang F; Graham P; El-Omar EM; Wu P, 2022, 'Dysbiosis in Head and Neck Cancer: Determining Optimal Sampling Site for Oral Microbiome Collection', Pathogens, 11, http://dx.doi.org/10.3390/pathogens11121550

Chen J; Zeng P; Gong L; Zhang X; Ling Z; Bi K; Shi F; Wang K; Zhang Q; Jiang J; Zhang Y; Uede T; El-Omar EM; Diao H, 2022, 'Osteopontin Exacerbates High-Fat Diet-Induced Metabolic Disorders in a Microbiome-Dependent Manner', mBio, 13, http://dx.doi.org/10.1128/mbio.02531-22

Hosseini-Giv N; Basas A; Hicks C; El-Omar E; El-Assaad F; Hosseini-Beheshti E, 2022, 'Bacterial extracellular vesicles and their novel therapeutic applications in health and cancer', Frontiers in Cellular and Infection Microbiology, 12, http://dx.doi.org/10.3389/fcimb.2022.962216

O'Donnell M; Teasdale S; Chua X-Y; Hardman J; Wu N; Curtis J; Samaras K; Bolton P; Morris M; Shannon-Weickert C; Purves-Tyson T; El-Assaad F; Jiang X; Hold G; El-Omar E; Wu N, 2022, 'The role of the microbiome in the metabolic health of people with schizophrenia and related psychoses: cross-sectional and pre-post lifestyle intervention analyses', Pathogens, 11, pp. 1279, http://dx.doi.org/10.3390/pathogens11111279

Luo Z; Li M; Yang J; Li J; Zhang Y; Liu F; El-Omar E; Han L; Bian J; Gong L; Wang M, 2022, 'Ferulic acid attenuates high-fat diet-induced hypercholesterolemia by activating classic bile acid synthesis pathway', Frontiers in Nutrition, 9, http://dx.doi.org/10.3389/fnut.2022.976638

Gemikonakli G; Mach J; Zhang F; Bullock M; Tran T; El-Omar E; Hilmer SN, 2022, 'Polypharmacy with high Drug Burden Index (DBI) alters the gut microbiome overriding aging effects and is reversible with deprescribing.', The Journals of Gerontology Series A, 78, http://dx.doi.org/10.1093/gerona/glac195

Huang YE; Shen X; Yin D; Lan S; Lu Y; Zhou P; Ma L; Zhang Y; Sheng Y; Zhang Y; Li M; Hu F; Chen J; Li P; El-Omar EM; Zheng H, 2022, 'Disrupted establishment of anaerobe and facultative anaerobe balance in preterm infants with extrauterine growth restriction', Frontiers in Pediatrics, 10, http://dx.doi.org/10.3389/fped.2022.935458

Malfertheiner P; Megraud F; Rokkas T; Gisbert JP; Liou JM; Schulz C; Gasbarrini A; Hunt RH; Leja M; O’Morain C; Rugge M; Suerbaum S; Tilg H; Sugano K; El-Omar EM; Agreus L; Bazzoli F; Bordin D; Loginov AS; Mario FD; Dinis-Ribeiro M; Engstrand L; Fallone C; Goh KL; Graham D; Kuipers EJ; Kupcinskas J; Lanas A; Machado JC; Mahachai V; Marshall BJ; Milosavljevic T; Moss SF; Park JY; Niv Y; Rajilic-Stojanovic M; Ristimaki A; Smith S; Tepes B; Wu CY; Zhou L, 2022, 'Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report', Gut, 71, pp. 1724 - 1762, http://dx.doi.org/10.1136/gutjnl-2022-327745

Sugano K; Spechler SJ; El-Omar EM; McColl KEL; Takubo K; Gotoda T; Fujishiro M; Iijima K; Inoue H; Kawai T; Kinoshita Y; Miwa H; Mukaisho KI; Murakami K; Seto Y; Tajiri H; Bhatia S; Choi MG; Fitzgerald RC; Fock KM; Goh KL; Ho KY; Mahachai V; O'Donovan M; Odze R; Peek R; Rugge M; Sharma P; Sollano JD; Vieth M; Wu J; Wu MS; Zou D; Kaminishi M; Malfertheiner P, 2022, 'Kyoto international consensus report on anatomy, pathophysiology and clinical significance of the gastro-oesophageal junction', Gut, 71, pp. 1488 - 1514, http://dx.doi.org/10.1136/gutjnl-2022-327281

Chen J; Zhao Y; Zhang F; Li J; Boland JA; Cheng NC; Liu K; Tiffen JC; Bertolino P; Bowen DG; Krueger A; Lisowski L; Alexander IE; Vadas MA; El-Omar E; Gamble JR; McCaughan GW, 2022, 'Liver-specific deletion of miR-181ab1 reduces liver tumour progression via upregulation of CBX7', Cellular and Molecular Life Sciences, 79, http://dx.doi.org/10.1007/s00018-022-04452-6

Siau K; Kulkarni AV; El-Omar E, 2022, 'How to be a Good Reviewer for a Scientific Journal', Journal of Clinical and Experimental Hepatology, 12, pp. 1238 - 1243, http://dx.doi.org/10.1016/j.jceh.2022.04.006

Mittinty MM; Lee JY; Walton DM; El-Omar EM; Elliott JM, 2022, 'Integrating the Gut Microbiome and Stress-Diathesis to Explore Post-Trauma Recovery: An Updated Model', Pathogens, 11, http://dx.doi.org/10.3390/pathogens11070716

Dong Y; Wu X; Han L; Bian J; He C; El-Omar E; Gong L; Wang M, 2022, 'The Potential Roles of Dietary Anthocyanins in Inhibiting Vascular Endothelial Cell Senescence and Preventing Cardiovascular Diseases', Nutrients, 14, http://dx.doi.org/10.3390/nu14142836

Li K; Xiao Y; Bian J; Han L; He C; El-Omar E; Gong L; Wang M, 2022, 'Ameliorative Effects of Gut Microbial Metabolite Urolithin A on Pancreatic Diseases', Nutrients, 14, http://dx.doi.org/10.3390/nu14122549

El-Omar EM, 2022, 'Genetic Predisposition for Helicobacter pylori Infection—The Jury Is Still Out!', Gastroenterology, 162, pp. 1591 - 1593, http://dx.doi.org/10.1053/j.gastro.2022.03.003

Xiao Y; Li K; Bian J; Liu H; Zhai X; El-Omar E; Han L; Gong L; Wang M, 2022, 'Urolithin A Attenuates Diabetes-Associated Cognitive Impairment by Ameliorating Intestinal Barrier Dysfunction via N-glycan Biosynthesis Pathway', Molecular Nutrition and Food Research, 66, http://dx.doi.org/10.1002/mnfr.202100863

Li Y; Zhang F; Zheng H; Kalasabail S; Hicks C; Fung KY; Preaudet A; Putoczki T; Beretov J; Millar EKA; El-Omar E; Jiang XT; Yim HCH, 2022, 'Fecal DNA Virome Is Associated with the Development of Colorectal Neoplasia in a Murine Model of Colorectal Cancer', Pathogens, 11, http://dx.doi.org/10.3390/pathogens11040457

Susic DF; Wang L; Roberts LM; Bai M; Gia A; McGovern E; Jiang XT; Davis GK; El-Omar E; Henry A, 2022, 'Corrigendum: The P4 Study: Postpartum Maternal and Infant Faecal Microbiome 6 Months After Hypertensive Versus Normotensive Pregnancy(Front. Cell. Infect. Microbiol., (2022), 12, (646165), 10.3389/fcimb.2022.646165)', Frontiers in Cellular and Infection Microbiology, 12, pp. 895332, http://dx.doi.org/10.3389/fcimb.2022.895332

Zhang N; Wang Z; Lv J; Zhang S; Liu Y; Liu T; Li W; Gong L; Zhang X; El-Omar EM; Lu W, 2022, 'Characterization of Gut Microbiota and Exploration of Potential Predictive Model for Hepatocellular Carcinoma Microvascular Invasion', Frontiers in Medicine, 9, http://dx.doi.org/10.3389/fmed.2022.836369

Amorim N; McGovern E; Raposo A; Khatiwada S; Shen S; Koentgen S; Hold G; Behary J; El-Omar E; Zekry A, 2022, 'Refining a Protocol for Faecal Microbiota Engraftment in Animal Models After Successful Antibiotic-Induced Gut Decontamination', Frontiers in Medicine, 9, http://dx.doi.org/10.3389/fmed.2022.770017

Shaw S; Berry S; Thomson J; Murray GI; El-Omar E; Hold GL, 2022, 'Gut Mucosal Microbiome Signatures of Colorectal Cancer Differ According to BMI Status', Frontiers in Medicine, 8, http://dx.doi.org/10.3389/fmed.2021.800566

Susic DF; Wang L; Roberts LM; Bai M; Gia A; McGovern E; Jiang XT; Davis GK; El-Omar E; Henry A, 2022, 'The P4 Study: Postpartum Maternal and Infant Faecal Microbiome 6 Months After Hypertensive Versus Normotensive Pregnancy', Frontiers in Cellular and Infection Microbiology, 12, pp. 646165, http://dx.doi.org/10.3389/fcimb.2022.646165

Nitschke P; Lodge S; Kimhofer T; Masuda R; Bong SH; Hall D; Schäfer H; Spraul M; Pompe N; Diercks T; Bernardo-Seisdedos G; Mato JM; Millet O; Susic D; Henry A; El-Omar EM; Holmes E; Lindon JC; Nicholson JK; Wist J, 2022, 'J-Edited DIffusional Proton Nuclear Magnetic Resonance Spectroscopic Measurement of Glycoprotein and Supramolecular Phospholipid Biomarkers of Inflammation in Human Serum', Analytical Chemistry, 94, pp. 1333 - 1341, http://dx.doi.org/10.1021/acs.analchem.1c04576

Inan-Eroglu E; Huang BH; Ahmadi MN; Johnson N; El-Omar EM; Stamatakis E, 2022, 'Joint associations of adiposity and alcohol consumption with liver disease-related morbidity and mortality risk: findings from the UK Biobank', European Journal of Clinical Nutrition, 76, pp. 74 - 83, http://dx.doi.org/10.1038/s41430-021-00923-4

Yan Z; Chen B; Yang Y; Yi X; Wei M; Ecklu-Mensah G; Buschmann MM; Liu H; Gao J; Liang W; Liu X; Yang J; Ma W; Liang Z; Wang F; Chen D; Wang L; Shi W; Stampfli MR; Li P; Gong S; Chen X; Shu W; El-Omar EM; Gilbert JA; Blaser MJ; Zhou H; Chen R; Wang Z, 2022, 'Multi-omics analyses of airway host–microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventions', Nature Microbiology, http://dx.doi.org/10.1038/s41564-022-01196-8

Behary J; Raposo AE; Amorim NML; Zheng H; Gong L; McGovern E; Chen J; Liu K; Beretov J; Theocharous C; Jackson MT; Seet-Lee J; McCaughan GW; El-Omar EM; Zekry A, 2021, 'Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2 −/− mouse model', BMC Microbiology, 21, pp. 113, http://dx.doi.org/10.1186/s12866-021-02171-9

Behary J; Amorim N; Jiang XT; Raposo A; Gong L; McGovern E; Ibrahim R; Chu F; Stephens C; Jebeili H; Fragomeli V; Koay YC; Jackson M; O’Sullivan J; Weltman M; McCaughan G; El-Omar E; Zekry A, 2021, 'Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma', Nature Communications, 12, pp. 187, http://dx.doi.org/10.1038/s41467-020-20422-7

Wands DIF; El-Omar EM; Hansen R, 2021, 'Helicobacter pylori: Getting to grips with the guidance', Frontline Gastroenterology, 12, pp. 650 - 655, http://dx.doi.org/10.1136/flgastro-2020-101571

Hathi Z; Mettu S; Priya A; Athukoralalage S; Lam TN; Choudhury NR; Dutta NK; El-Omar EM; Gong L; Mohan G; Lin CSK, 2021, 'Methodological advances and challenges in probiotic bacteria production: Ongoing strategies and future perspectives', Biochemical Engineering Journal, 176, http://dx.doi.org/10.1016/j.bej.2021.108199

Wu N; Mah C; Koentgen S; Zhang L; Grimm MC; El-Omar E; Hold GL, 2021, 'Inflammatory bowel disease and the gut microbiota', Proceedings of the Nutrition Society, 80, pp. 424 - 434, http://dx.doi.org/10.1017/S002966512100197X

Gong L; El-Omar EM, 2021, 'Application of molecular techniques in Helicobacter pylori detection: limitations and improvements', Helicobacter, 26, http://dx.doi.org/10.1111/hel.12841

Schupfer E; Pak SC; Wang S; Micalos PS; Jeffries T; Ooi SL; Golombick T; Harris G; El-Omar E, 2021, 'The effects and benefits of arabinoxylans on human gut microbiota – A narrative review', Food Bioscience, 43, http://dx.doi.org/10.1016/j.fbio.2021.101267

Back to profile page